The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 19, 2011
Filed:
Aug. 01, 2008
Shon Booker, Thousand Oaks, CA (US);
Noel D'angelo, Thousand Oaks, CA (US);
Derin C. D'amico, Newbury Park, CA (US);
Tae-seong Kim, Thousand Oaks, CA (US);
Longbin Liu, Thousand Oaks, CA (US);
Kristin Meagher, Thousand Oaks, CA (US);
Mark H. Norman, Thousand Oaks, CA (US);
Kathleen Panter, Cambridge, MA (US);
Laurie B. Schenkel, Boston, MA (US);
Adrian L. Smith, Simi Valley, CA (US);
Nuria A. Tamayo, Newbury Park, CA (US);
Douglas A. Whittington, Waltham, MA (US);
Ning Xi, Thousand Oaks, CA (US);
Kevin Yang, San Gabriel, CA (US);
Shon Booker, Thousand Oaks, CA (US);
Noel D'Angelo, Thousand Oaks, CA (US);
Derin C. D'Amico, Newbury Park, CA (US);
Tae-Seong Kim, Thousand Oaks, CA (US);
Longbin Liu, Thousand Oaks, CA (US);
Kristin Meagher, Thousand Oaks, CA (US);
Mark H. Norman, Thousand Oaks, CA (US);
Kathleen Panter, Cambridge, MA (US);
Laurie B. Schenkel, Boston, MA (US);
Adrian L. Smith, Simi Valley, CA (US);
Nuria A. Tamayo, Newbury Park, CA (US);
Douglas A. Whittington, Waltham, MA (US);
Ning Xi, Thousand Oaks, CA (US);
Kevin Yang, San Gabriel, CA (US);
Amgen Inc., Thousand Oaks, CA (US);
Abstract
The present invention comprises a new class of compounds capable of modulating the activity of PI3 kinase and, accordingly, useful for treatment of PI3 kinase mediated diseases, including melanomas, carcinomas and other cancer-related conditions. The compounds have a general Formula I wherein each of A, A, A, A, X, Rand Rare defined herein. The invention further comprises pharmaceutical compositions, methods for treatment of PI3 kinase mediated diseases, and intermediates and processes useful for the preparation of compounds of the invention.